𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Effects of the mTOR inhibitor sirolimus in patients with hepatocellular and cholangiocellular cancer

✍ Scribed by Magnus Rizell; Mats Andersson; Christian Cahlin; Larsolof Hafström; Michael Olausson; Per Lindnér

Book ID
106285031
Publisher
Springer
Year
2008
Tongue
English
Weight
223 KB
Volume
13
Category
Article
ISSN
1341-9625

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Interleukin-6 in transcatheter arterial
Interleukin-6 in transcatheter arterial embolization for patients with hepatocellular carcinoma. Effects of serine protease inhibitor
✍ Yukihiko Matsuda; Sumio Kawata; Toshihiko Nagase; Yuichi Maeda; Eiji Yamasaki; S 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 446 KB 👁 2 views

Background. Modulation of serum levels of circulating cytokines and inflammatory responses with a serine protease inhibitor was studied in 34 patients with hepatocellular carcinoma (HCC) after transcatheter arterial embolization (TAE). Methods. The 34 patients were randomly divided into two groups:

In vivo antitumor effect of the mTOR inh
In vivo antitumor effect of the mTOR inhibitor CCI-779 and gemcitabine in xenograft models of human pancreatic cancer
✍ Daisuke Ito; Koji Fujimoto; Tomohiko Mori; Kazuhiro Kami; Masayuki Koizumi; Eiji 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 459 KB

## Abstract Mammalian target of rapamycin (mTOR) is considered to be a major effector of cell growth and proliferation that controls protein synthesis through a large number of downstream targets. We investigated the expression of the phosphatidylinositol 3′‐kinase (PI3K)/mTOR signaling pathway in